207 related articles for article (PubMed ID: 28415766)
1. Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.
Khandia R; Pattnaik B; Rajukumar K; Pateriya A; Bhatia S; Murugkar H; Prakash A; Pradhan HK; Dhama K; Munjal A; Joshi SK
Oncotarget; 2017 May; 8(22):35835-35847. PubMed ID: 28415766
[TBL] [Abstract][Full Text] [Related]
2. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
[TBL] [Abstract][Full Text] [Related]
4. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
5. Production of recombinant lethal factor of
Gholami M; Moghbeli M; Kafilzadeh F; Kargar M; Torbati MB; Tavizi A; Bellevile S; Hatami J; Eslami Z
Prep Biochem Biotechnol; 2021; 51(1):9-15. PubMed ID: 32393098
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of B. anthracis toxins during ex vivo phagocytosis.
Tarasenko O; Scott A; Jones A; Soderberg L; Alusta P
Glycoconj J; 2013 Jul; 30(5):473-84. PubMed ID: 22983705
[TBL] [Abstract][Full Text] [Related]
7. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
[TBL] [Abstract][Full Text] [Related]
9. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
Chvyrkova I; Zhang XC; Terzyan S
Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
[TBL] [Abstract][Full Text] [Related]
10. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies.
Varughese M; Chi A; Teixeira AV; Nicholls PJ; Keith JM; Leppla SH
Mol Med; 1998 Feb; 4(2):87-95. PubMed ID: 9508786
[TBL] [Abstract][Full Text] [Related]
11. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
13. Anthrax toxin: the long and winding road that leads to the kill.
Abrami L; Reig N; van der Goot FG
Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
[TBL] [Abstract][Full Text] [Related]
14. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
[TBL] [Abstract][Full Text] [Related]
15. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen.
Elliott JL; Mogridge J; Collier RJ
Biochemistry; 2000 Jun; 39(22):6706-13. PubMed ID: 10828989
[TBL] [Abstract][Full Text] [Related]
17. Toxins of Bacillus anthracis.
Brossier F; Mock M
Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
[TBL] [Abstract][Full Text] [Related]
18. Single-step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli.
Chang HH; Tsai MF; Chung CP; Chen PK; Hu HI; Kau JH; Huang HH; Lin HC; Sun DS
J Biotechnol; 2006 Nov; 126(3):277-85. PubMed ID: 16797097
[TBL] [Abstract][Full Text] [Related]
19. [Anthrax toxins].
Brossier F; Guidi-Rontani C; Mock M
C R Seances Soc Biol Fil; 1998; 192(3):437-44. PubMed ID: 9759382
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
